Off-Label Use of Atypical Antipsychotics Increases Diabetes Risk Among Elderly
From the PharmaLive.com News Archive - May. 13, 2010
A new study yields important new evidence that the use of atypical
antipsychotics among the elderly for off-label purposes is associated
with increased risk of developing diabetes.
www.peoplewho.org